CA Patent

CA2091194A1 — 2-oxo-ethyl derivatives as immunosuppressants

Assigned to Bayer Corp · Expires 1993-10-09 · 33y expired

What this patent protects

ABSTRACT A class of compounds which suppress human T-lymphocyte proliferation is disclosed. The active compounds essentially contain at least the following structure:

USPTO Abstract

ABSTRACT A class of compounds which suppress human T-lymphocyte proliferation is disclosed. The active compounds essentially contain at least the following structure:

Drugs covered by this patent

Patent Metadata

Patent number
CA2091194A1
Jurisdiction
CA
Classification
—
Expires
1993-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.